Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
By J. Ferlay, M. Colombet, Isabelle Soerjomataram, Colin D Mathers, D. Parkin, M. Piñeros, A. Znaor, F. Bray. International Journal of Cancer, 2018
6,627 citations recorded by the source corpus.
Estimates of the worldwide incidence and mortality from 36 cancers and for all cancers combined for the year 2018 are now available in the GLOBOCAN 2018 database, compiled and disseminated by the International Agency for Research on Cancer (IARC). This paper reviews the sources and methods used in compiling the cancer statistics in 185 countries. The validity of the national estimates depends upon the representativeness of the source information, and to take into account possible sources of bias, uncertainty intervals are now provided for the estimated sex‐ and site‐specific all‐ages number of new cancer cases and cancer deaths. We briefly describe the key results globally and by world region. There were an estimated 18.1 million (95% UI: 17.5–18.7 million) new cases of cancer (17 million excluding non‐melanoma skin cancer) and 9.6 million (95% UI: 9.3–9.8 million) deaths from cancer (9.5 million excluding non‐melanoma skin cancer) worldwide in 2018.
Subfields: Economics and Econometrics, Oncology
View Paper: https://www.semanticscholar.org/paper/29895cd62b71bee9044e30b6e7a41990bdce1561
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
In Oncology
- J. Ferlay
- F. Bray
- Isabelle Soerjomataram
- M. Colombet
- D. M. Parkin
- A. Jemal
- R. Siegel
- Prashanth Rawla
Citations in the corpus
- Cancer statistics for the year 2020: An overview (2021, methodology): “The methods of incidence and mortality estimation and the computation of uncertainty intervals are similar to those used in the previous estimates.(1) These are reproduced in Annex A and summarised later.”
- The global burden of urinary bladder cancer: an update (2019, background): “Assessing the burden of UBC worldwide is reliant upon the availability of cancer registry data [3].”